JP Morgan Chase
EVOK

JP Morgan Chase’s Evoke Pharma EVOK Stock Holding History

JP Morgan Chase’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Hold
0
– – – 5707
2020
Q3 		– Hold
0
– – – 5545
2020
Q2 		– Hold
0
– – – 5461
2018
Q4 		– Sell
-259
Closed -$111K – 5744
2018
Q3 		$111K Buy
+259
New +$103K ﹤0.01% 4908

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

JP Morgan Chase's EVOK Position: Q4 2020 in Review

JP Morgan Chase held its Evoke Pharma (EVOK) position steady in Q4 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5707.

JP Morgan Chase first reported a position in EVOK in Q3 2018 and has held it in 1 quarter since. The position peaked at $111K in Q3 2018. 30 funds tracked by Wall St. Rank hold EVOK as of Q4 2020.

  • JP Morgan Chase held 0 shares of Evoke Pharma worth $0 as of Q4 2020.
  • JP Morgan Chase left its Evoke Pharma share count unchanged in Q4 2020.
  • Evoke Pharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q4 2020, its #5707 holding.
  • JP Morgan Chase first reported a position in Evoke Pharma in Q3 2018 and has held it in 1 quarter since.
  • JP Morgan Chase's Evoke Pharma position peaked at $111K in Q3 2018.
  • 30 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.